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ABSTRACT
COVID-19 is an established threat whose clinical features 
and epidemiology continues to evolve. In an effort to 
contain the disease, the National Health Service has 
adopted a digital first approach in UK general practice 
resulting in a significant shift away from face- to- face 
consultations. Consequently, more consultations are being 
completed without obtaining objective recording of vital 
signs and face- to- face examination. Some regions have 
formed hot hubs to facilitate the review of suspected 
COVID-19 cases and keep their practice site ‘clean’ 
including the use of doorstep observations in avoiding 
the risk of face- to- face examination. To support the safe, 
effective and efficient remote assessment of suspected 
and confirmed patients with COVID-19, we established a 
doorstep assessment service to compliment telephone and 
video consultations. This allows physiological parameters 
such as temperature, pulse, blood pressure and oxygen 
saturation to be obtained to guide further triage. Quality 
improvement methods were used to integrate and optimise 
the doorstep assessment and measure the improvements 
made. The introduction of a doorstep assessment service 
increased the proportion of assessments for patients with 
suspected COVID-19 in routine care over weeks. At the 
same time we were able to dramatically reduce face- 
to- face assessment over a 6- week period by optimising 
through a range of measures including the introduction 
of a digital stethoscope. The majority of patients were 
managed by their own general practitioner following 
assessment supporting continuity of care. There were 
no adverse events during the period of observation; no 
staff absences related to COVID-19. Quality improvement 
methods have facilitated the successful integration of 
doorstep assessments into clinical care.
PROBLEM
The COVID-19 is an established healthcare 
threat whose epidemiology continues to 
evolve.1 In an effort to contain the disease, 
the National Health Service (NHS) has 
adopted a digital first approach in UK general 
practice resulting in a significant shift away 
from traditional face- to- face consultations.2 
In response to the pandemic, general prac-
titioners (GPs) have moved to a total triage 
model following NHS England guidelines.2 
Using online, telephone and video consulta-
tions to reduce avoidable footfall in practice 
and protect patients and staff from infec-
tion.3 Consequently, more consultations are 
being completed without obtaining objec-
tive recording of vital signs and face- to- face 
examination.4 Some regions have formed 
hot hubs to facilitate the review of suspected 
COVID-19 cases and keep their practice site 
‘clean’ including the use of doorstep obser-
vations in avoiding the risk of traditional face- 
to- face examination.5
Prior to 20 April 2020, there were 152 
confirmed cases of COVID-19 for 34 prac-
tices in St. Helens covering a population of 
~192 000. A retrospective case audit of 4831 
patients in a single surgery in the same popu-
lation prior to 22 April 2020 identified 21 
patients with suspected COVID-19 (0.4% of 
population). While all of these patients had 
a remote assessment, only two had a physical 
assessment (10%), and both of these were 
done in an urgent care setting; none (0%) 
were done in routine care. Two of the patients 
with suspected COVID-19 went to hospital 
without prior examination in primary care 
(10%). There was one death with COVID-19 
on the certificate in one of the hospitalised 
patients. A GP provider group of 26 practices 
in the St. Helens area covering a total popu-
lation of 140 957 patients setup a local hot 
hub following discussions about local service 
needs in response to the COVID-19 pandemic. 
The hub was staffed by participant practice 
GPs and advanced nurse practitioners who 
have volunteered and meet ‘lower infection 
risk’ assessment. The aim of the service was to 
allow community assessment of those patients 
with suspected COVID-19 infection who are 
not able to attend the hot clinic while mini-
mising exposure to primary care workforce 
and community spread. The service was 
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commenced on 22 April 2020 and planned to run until 
30 June 2020 with the doorstep assessment introduced 
on 27 April 2020; this was in anticipation of the peak of 
COVID-19 in early May, ~2 weeks behind that in London. 
A retrospective case review of patients reviewed at the hot 
hub in the week prior to the introduction of the door-
step assessment service indicated that all patients (4) 
were receiving traditional face- to- face assessment in full 
personal protective equipment (PPE).
The SMART objectives assessed in this study include: 
(1) increase the proportion of assessments of vital signs 
for patients with suspected COVID-19 in routine care 
by 10% in 2 months (baseline 0%) and (2) increase the 
proportion of non- face- to- face assessments for patients 
with suspected COVID-19 at the hot hub by 10% in 
2 months (baseline 0%). Other outcomes to be reported 
includes: (3) number of doorstep assessments in patients 
with suspected COVID-19; (4) absences from work due 
to COVID-19 among clinicians; (5) hospitalisations of 
clinicians from COVID-19; (6) hospital admissions from 
doorstep assessment service; (7) number of deaths within 
4 weeks of using the doorstep assessment service; and 
(8) number of adverse event and serious adverse events 
within the doorstep assessment service.
BACKGROUND
COVID-19 is an established threat whose clinical and 
epidemiological characteristics continue to evolve.1 In an 
effort to contain the disease, the NHS has recommended 
that remote consultations should be used when possible 
resulting in a significant shift away from in- person tradi-
tional face- to- face consultation.2 To support the safe, effec-
tive and efficient assessment of patients with suspected 
and confirmed COVID-19, we established a doorstep 
assessment service to compliment telephone and video 
consultations. This allows physiological parameters such 
as pulse, and temperature and oxygen saturation to be 
obtained to support further triage.
What existing evidence is there that this problem exists?
COVID-19 is a significant cause of morbidity and mortality 
globally with the UK having among the highest mortality 
rate in the world.6 Notably, health professionals are at 
increased risk of contracting COVID-19.7 Patients with 
suspected COVID-19 who need face- to- face examination 
beyond telephone or video consultation are typically 
assessed in either the GP surgery, the patient’s home, 
the local hot hub or admitted directly to hospital. There 
have also been a number of significant events across the 
uk related to a failure to assess physiological parameters 
that has resulted in avoidable deaths in patients with 
COVID-19 not least failures to identify silent hypoxia. 
To complicate the situation further, full PPE in primary 
care has been in short supply, and there is a widespread 
concern about personal safety.8 Even with the availability 
of PPE, risk assessments meant that some clinicians were 
unable to conduct face- to- face assessments.9
What evidence is there that other people have tried to solve 
this problem in the past?
Novel smartphone apps such as LifeLight that attempt to 
measure blood pressure, pulse respiratory rate and pulse 
oximetry without making physical contact with the patient 
have not as yet been validated to the standard required 
for accurate and safe assessment in acute primary care.10 
On demand home- based self- guided examination devices 
are commercially available. Devices such as Tytohome 
are designed for mobile capture and transmission of ear, 
throat and skin images, heart and lung auscultation and 
temperature but not blood pressure and oxygen satura-
tion.11 The current retail cost of each device is ~£236. The 
device is Food and Drug Administration (FDA) approved 
and have been evaluated in feasibility studies in clini-
cally stable patients in the USA. There are no published 
reports that they have been used in COVID-19 and no 
data relating to their use in elderly patients. Remote 
assessment of patients with stable chronic disease using 
kiosks has also been reported. These are often placed in 
strategic locations in the community and clinical setting to 
provide remote access to a diagnostic assessment but are 
not suitable for doorstep assessment. During the current 
pandemic, other clinical commissioning groups have 
established an oxygen saturation probe monitor drop and 
collect service but as yet no data have been published.5 
Equality and diversity issues have been reported in rela-
tion to the use of some technology used in remote assess-
ment, especially those that require the use and operations 
of a mobile phone.
Is there any evidence for what works and what does not to 
solve your problem?
The equipment proposed for use in our doorstep assess-
ment has been extensively researched and approved 
by the Medicines and Healthcare products Regulatory 
Agency (MHRA). As COVID-19 is an emerging disease, 
evidence of what works in terms of assessment remains 
limited. National Early Warning Score 2 (NEWS2) 
includes blood pressure measurement and oxygen satu-
ration, although use has been suggested without the need 
for Blood Pressure (BP) if measurement does not alter 
management. There is no high- quality research on the 
value of NEWS2 outside of the hospital setting. If used, it 
should be done so alongside wider clinical assessment of 
the patient and in the context of changes over time. For 
the rapid diagnosis of suspected pneumonia in COVID-
19, temperature, pulse oximetry, respiratory rate and 
heart rate are required. Blood pressure and auscultation 
should be reserved for situations where it will help to alter 
management when clinically indicated.
MEASUREMENT
Initial data collection focused on the number of assess-
ments at the hot hub clinic during a single working week 
prior to the implementation to the doorstep assessment 
service to get a ‘snap shot’ of the problem. A retrospective 
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case analysis was undertaken to identify the number of 
appointments that were available and how many tradi-
tional face- to- face appointments were being undertaken 
along with how much PPE was being used. In order to 
meet our project aim, we used the electronic medical 
record to measure the number of appointments avail-
able for both the doorstep assessment and hot hub clinic 
and the number of face- to- face assessments undertaken 
in both the doorstep assessment service and hot hub. 
Hospital admissions and deaths were also measured as 
secondary outcomes as they formed part of routine data 
collection. The cost of the service was also quantified.
DESIGN
The doorstep assessment service was established along-
side the implementation of a COVID-19 hot hub by St. 
Helens Clinical Commissioning Group (CCG). The 
quality improvement team included the local COVID-19 
lead for primary care (SC), primary care network lead 
(DL), healthcare assistants (HCAs) (HJ), hot hub practice 
manager (CW) and local GPs (AT, DL, GI, HP, SC). The 
aim of the service was to allow community assessment of 
those patients with suspected COVID-19 infection while 
minimising exposure to primary care workforce and 
community spread. If needed, patient could be referred 
on for further assessment at the hot clinic, admitted to 
Accident and Emergency department (A+E) or managed 
by their own GP. A standard operating procedure (online 
supplemental appendices 1–8) was developed based on 
the application of principles of COVID-19 risk reduction 
for NHS staff—elimination if possible by minimising 
traditional face- to- face contact, hygiene measures and 
safe systems of work with election of correct use of PPE 
when needed (online supplemental appendices 9–11).7 
Children were not included in the service. We followed 
the best available evidence emerging from the literature 
for how clinical assessment of patients with suspected and 
confirmed COVID-19 should be assessed; action points 
from regional significant event reports relating to need 
for physical assessment to take place where needed; 
epidemiological data identifying high- risk populations; 
and equality and diversity considerations including a 
need to provide care for shielded patients. We engaged 
with stakeholders in the development of the service 
through a weekly series of remote meetings. We refined 
our protocol by simulating assessments. A premortem 
analysis of the proposed service was undertaken to antic-
ipate potential problems: lack of guidance and training 
on how to undertake an assessment; technology failure; 
infection control issues; and equality and diversity issues.
Suitable inclusion criteria include those patient with 
symptoms consistent with COVID-19 when a clinician 
in general practice has completed a telephone/video 
assessment and feels obtaining a NEWS2 score and more 
specifically an oxygen saturation would change manage-
ment (online supplemental appendices 1–5). Notably, 
this included housebound patients or patients without 
own transport. In addition, clinicians at the hot hub who 
would potentially be undertaking face- to- face assessment 
on referred patients were also able to retriage patients 
referred for traditional face- to- face assessment to the 
doorstep assessment service if needed. Two forms of door-
step assessment review are available: (1) an assessment 
review for observations only undertaken by the patient 
themselves with support of a visiting HCA if needed or 
(2) a diagnostic review undertaken by a GP via video link 
with full vital signs (figure 1).The assessment involved 
delivering the assessment at the earliest opportunity and 
within the time frame of the review request. The equip-
ment required to undertake the assessment is listed in 
box 1.
The implementation team met remotely about every 
4 weeks during the service. Providers and staff were educated 
about the service and questions about clinical flow were 
answered. New providers and staff, when orientated from 
doorstep assessment champions, were provided with an 
Figure 1 Doorstep assessment care pathway.
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induction manual and were included in meetings were 
appropriate.
To ensure the sustainability of the service, we aimed to 
empower frontline staff and service users. We used data to 
identifiy and variation in performance and measure the 
impact of the service over time. We planned for the service 
to be scaled up and extended post- COVID-19 with adaption 
to local needs, new environments, patient and staff groups by 
making use of currently available equipment and resources 
and becoming the new way of operating
STRATEGY
In our first PDSA cycle, we decided to implement the assess-
ment service for patients with suspected COVID-19 carried 
out by HCAs. This was done to find out the impact of running 
the service during a busy time for the local primary service 
during the pandemic. After discussions with the partici-
pating practices and St. Helens CCG. doorstep assessment 
result could also be entered directly into the patient’s notes 
using Egton Medical Information System (EMIS) Enterprise. 
This PDSA cycle was done primarily to test feasibility of the 
service for patients. Informal feedback from staff, providers 
and patients were mostly positive and was used to inform our 
second cycle. Only 15% of patients using the service were 
male. The mean age of patient mean age of patients was 54 
(range 21–83) years. A small number of referrals received 
were not appropriate for the service.
For PDSA cycle 2, we enabled referrals to be made directly 
through EMIS using the existing extended access appoint-
ment booking service. We introduced an online template 
for clinicians to follow when making a booking to ensure 
the referrals received were appropriate. We shared emerging 
UK observational data for risk of death and relevant service 
perfromance data, encouraging GP surgeries to have a low 
threshold for referring individuals at high risk of death. We 
tailored the service to align with local and national NHS 
England recommendations on shielding and testing. For 
PDSA cycle 3, we assigned hot hub champions to help main-
tain continuity and share experience within the service. A 
digital stethoscope (Thinklabs) was made available to clini-
cians at the hot hub. One of the GP assistants was trained to 
set this up for clinicians to use.
RESULT
The main outcomes for the study were change in the 
proportion of assessments of vital signs for patients with 
suspected COVID-19 in routine care and change in the 
proportion of non- face- to- face assessments for patients 
with suspected COVID-19 at the hot hub. At baseline, all 
patients were being assessed through traditional face- to- 
face assessment at the hot hub. After PDSA 1 with the 
introduction of the doorstep assessment, 27% of patients 
had non face- to- face assessments. This increased to 
28% after PDSA cycle 2% and 100% after PDSA cycle 3 
(figure 2)
On the single day when the doorstep assessment service 
was not available, the proportion of traditional face- 
to- face assessments reverted back to 100%. At baseline, 
there was no doorstep assessment service available, and 
therefore, no extra physical assessment made. After PDSA 
1 with the introduction of the doorstep assessment, 27% 
(20) of patients had non face- to- face assessments. This 
increased to 28% (23) after PDSA cycle 2 and 100% (43) 
after PDSA cycle 3 (figure 3).
The total number of doorstep assessments carried out 
over the three 2- week cycles was 61 (PDSA 1=20, PDSA 
2=23 and PDSA 3=18) (figure 2). There were five (8%) 
hospital admissions to hospital from the doorstep assess-
ment service; in one case, an ambulance was called prior 
to the arrival of the GP assistant. Four of these patients 
referred from the doorstep assessment went on to have 
COVID-19 (mean duration of admission 5 days, range 
1–12). This compares with seven admissions (5%) from 
the 138 patients reviewed at the hot hub over the same 
time period (figure 4). Five of the patient referred 
from the hot hub patient went on to have a diagnosis of 
COVID-19 (mean duration of admission 5 days, range 
1–13) (figure 4). All remaining assessments 56 (92%) 
were followed up by the patient’s usual GP. Three patients 
had a follow- up doorstep assessment. No patient who 
underwent a door step assessment went on to have an 
assessment in the hot hub or vice versa. There were no 
patient deaths within 4 weeks of using the doorstep assess-
ment service. There were no adverse events or significant 
adverse events associated with the doorstep assessment 
service. Data from one of the referring GP surgeries 
(list size 4831 patients) during the period of the project 
reported 11 cases of suspected COVID-19. Of these, 
seven were referred for the doorstep assessment service 
Figure 2 Proportion of non- face- to- face assessments.
Box 1 Doorstep assessment drop box equipment
 ► Equipment.
 ► Pulse oximeter.
 ► Digital thermometer.
 ► Sphygmomanometer with disposable cuff.
 ► Tablet with Wi- Fi.
 ► Digital stethoscope (Plan, Do, Study, Act (PDSA) 3 only).
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and one to the hot hub. Three patient did not have any 
further assessment (mean age 34 years). For these three 
patients, assessment beyond video consultation was not 
considered necessary by the GP. All three patients made 
a full recovery. All patients with frailty were reviewed 
through the doorstep assessment service. There were no 
clinical staff absences with suspect COVID-19, and no 
clinicians were hospitalised with COVID-19. The mean 
age of patients assessed with the doorstep assessment was 
56 (range 21–84) years, and 26% were male. The cost of 
running the service using the GP assistant was £520 per 
week. The cost of the drop box was £50 for the basic box 
(oxygen saturation monitor: £25 and blood pressure 
machine: £25), £100 with a tablet included (Amazon 
Fire: £60) and £507 with a digital stethoscope (Thinklabs 
stethoscope: £397).
Lessons and limitations
The project’s aim was to try to increase the proportion 
of assessments of vital signs for patients with suspected 
COVID-19 at the same time increase the proportion of 
non- face- to- face assessments for these patients, which was 
achieved. Trying to improve the quality of the doorstep 
assessment service during the COVID-19 pandemic was 
challenging given the evolving nature of the pandemic, 
changing public health measures and the emergence 
and evolution of new evidence and guidelines during 
the pandemic. Establishing PDSA cycles and regularly 
communicating back to hub was vital given the changing 
situation so that the service could adjust and adapt. Given 
the cooperative nature in which the service was run, 
there was a relatively high turnover of clinicians running 
the hot hub service, which made establishing and main-
taining expertise within the service challenging in terms 
of maintaining institutional knowledge and expertise. 
In contrast, we were fortunate to have a small number 
of GP assistants (three) running the doorstep assessment 
service.
Evaluating data from the service within the PDSA cycles 
was useful in that it allowed us to identify that service was 
not necessarily being used in patients at the highest risk of 
death, for example, male, elderly and obese.12 The typical 
GP surgery in St. Helens has approximately ~38% male 
population. Coupled with this, the proportion of males 
contacting their GP with suspected COVID-19 symptoms 
appears to be lower than in females. There is also a long 
history of late presentations with other illnesses such a 
cancer and cardiovascular disease in male population 
in the region. We hypothesise that male patients are 
presenting later with more severe symptoms and going 
directly to secondary care. It also highlights the potential 
for inequality when introducing such a service and that 
the inverse care law may be in operation.13
Establishing a baseline during the pandemic was diffi-
cult given the changing epidemiology of the disease 
and the reconfiguration of local services. The baseline 
measurement period was relatively short due to: (1) 
patient and practitioner safety concerns along with (2) 
local and national concerns regarding the availability of 
effective PPE and (3) increasing patient demand. The 
target of a 10% increase in the proportion of patients with 
vital signs assessment and the 10% increase in non- face- 
to- face assessments was arbitrary and should we conduct 
the project again would recommend a much higher 
target of 50%–100% as we found it at least theoretically 
possible for all assessments to be conducted non- face- to- 
face. The study was conducted during the first lockdown, 
and the number of patients presenting to local GPs with 
suspected COVID-19 symptoms was falling in PDSA cycle 
3, and as a result, the number of physical observations 
remained static. Future research under experimental 
Figure 3 Number of physical assessments over time.
Figure 4 Patient flow through the hot hub and doorstep 
assessment service.
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conditions would help to evaluate the safety and effective-
ness of doorstep assessments.
The changes made in PDSA 2 resulted in a marginal 
improvement in reducing the proportion of traditional 
face- to- face contacts with PPE. In contrast, the introduc-
tion of the digital stethoscope in PDSA 3 resulted in a step 
change, which eliminated traditional direct face- to- face 
contact. Training one of the GP assistants to set up the 
stethoscope for clinicians reduced the anxiety of using 
a new device. The lack of utilisation of the remote video 
consultation service was surprising given the attention this 
has received nationally. Some clinicians felt this was ‘not 
needed’ and ‘added little to assessment over the phone’. 
A number of regions have established a hot hub service, 
but to our knowledge, relatively few have introduced a 
doorstep assessment service. We anticipate that our find-
ings may be useful should a second wave of COVID-19 or 
future pandemic occur. We reflected on the scalability 
of the intervention using the Intervention Scalability 
Assessment Tool identified workforce provision as a key 
challenge.14 We achieved this during the project through 
a high level of cooperation between local GP providers, 
but we are now looking to make this more sustainable by 
linking this workforce provision with the roll out of NHS 
virtual wards. Evaluating the service through a quality 
improvement project has helped to facilitate local discus-
sions on how urgent care could be better coordinated 
following the COVID-19 pandemic given that a number of 
the findings and service changes were felt to be generalis-
able to the existing and emerging urgent care and chronic 
disease services; indeed, the doorstep assessment service 
has recently been adopted locally by the community 
nursing team to assist with chronic disease management.
CONCLUSIONS
To our knowledge, this is the first quality improvement 
project completed during the COVID-19 pandemic. 
The doorstep assessment service was able to increase the 
proportion of assessment completed for patients with 
suspected COVID-19 while at the same time reducing the 
number of traditional face- to face assessments required 
and preserving PPE equipment. The majority of patients 
undergoing a doorstep assessments are followed up 
by their own GP maintaining continuity of care rather 
than leading to admission to hospital. Further evalua-
tion of doorstep assessment services under experimental 
conditions would help to establish their utility beyond 
the COVID-19 pandemic and whether their use should 
be scaled up and spread in urgent care and different 
settings, for example, care homes, work places and local 
communities.
Correction notice This article has been corrected since it was published. A 
misplaced ‘The’ has been removed from the starting of the abstract.
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